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in 1.2% of patients in the pre-mask period and 0.2% in the
mask period (P ¼ .12). Patients with RVI required more peri-
transplant care (median 76 days vs. 21 days, P< .0001). These
data suggest that requiring all individuals with direct patient
contact to wear a surgical mask can reduce the incidence of
RVI, particularly PIV3, during the vulnerable period following
HSCT.322
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Objective: Previous studies suggest that edentulous
(subjects without teeth) have a lower inﬂammatory state
than non-edentulous individuals probably due to peri-
odontal infection in non-edetulous subjects. We hypothe-
sized that edentulous patients would have a lower incidence
of bacteremia and other complications associated with
autotransplantation for multiple myeloma (MM).
Methods: We conducted a retrospective case-control study
of patients who received autologous hematopoietic stem cell
transplantation (AHSCT) for multiple MM at the Audie L.
Murphy Memorial Veterans Hospital Bone Marrow Trans-
plant Unit, in San Antonio, Texas from January 2003 through
September 2012. Case subjects were deﬁned as edentulous
and controls were deﬁned as non-edentulous. The 2 groups
were matched for age, gender, ethnicity, MM stage, time
from diagnosis to transplant, performance status, and
conditioning regimen. The following posttransplant toxic-
ities were analyzed: bacteremia, oral mucositis, nausea/
vomiting, diarrhea, neutrophil engraftment and length of
hospital stay.Table 1
Post-AHSCT patient toxicities
Edentulous
N¼45
Control Group
N¼90
P-value
Bacteremia, n (%) 0.553
Yes 11 (24) 18 (20)
No 34 (76) 72 (80)
Oral mucositis, n (%) 0.465
Grade 0 13 (29) 33 (37)
Grade 1 16 (36) 21 (23)
Grade 2 13 (29) 27 (30)
Grade 3 3 (7) 9 (10)
Nausea/Vomiting, n (%) 0.744
Grade 0 4 (9) 7 (8)
Grade 1 24 (53) 40 (44)
Grade 2 14 (31) 36 (40)
Grade 3 3 (7) 7 (8)
Diarrhea, n (%) 0.095
Grade 0 6 (13) 10 (11)
Grade 1 7 (16) 17 (19)
Grade 2 15 (33) 24 (27)
Grade 3 14 (31) 39 (43)
Grade 4 3 (7) 0 (0)
Days to ANC engraftment 0.966
Mean (SD) 10.84 (1.80) 10.83 (1.16)
Range 8-31 9-17
Length of hospital stay
(days)
0.098
Mean (SD) 15.76 (4.94) 17.47 (5.99)
Range 3-30 3-52Results: During the study period, 297 AHSCT were per-
formed at our institution. Of these, 45 (15%) patients were
found to be edentulous at the time of ﬁrst AHSCT. Forty-
ﬁve case subjects were matched to 90 controls. All
patients were males, their median age was 60 years
(range, 42-75), their Karnofsky performance status score
mean was 90 (range, 70-90), and all received melphalan as
part of the conditioning regimen. The majority of patients,
90 (67%) had stage III MM at transplantation and the
median time from diagnosis to transplantation was 12
months (range, 4-103).
The incidence and severity of all posttransplant toxicities
analyzed were similar in both groups (see Table 1). Thirty-
eight (84%) of edentulous patients were smokers or had
a history of smoking at the time of AHSCT compared to 58
(64%) of the control group (P ¼ .016). Overall survival after
transplant was similar in both groups.
Conclusions: The incidence of toxicities after AHSCT
experienced by edentulous MM patients was similar to
controls including bacteremia and oral mucositis. There
was a strong association between edentulism and
smoking.323
Polymicrobial and Multiple Microbiologically Proven
Infections in HSCT Recipients
Steven Triﬁlio 1, Marcelo Villa 2, Jayesh Mehta 3. 1 Northwestern
University; Jessica Fong, Northwestern Memorial Hospital;
2 Cell Therapy Processing Facility, Northwestern Memorial
Hospital, Chicago, IL; 3Northwestern Memorial Hospital,
Chicago, IL
Microbiologically conﬁrmed infections (MCI) which occur
during stem cell transplantation (HSCT) increase morbidity
andmortality. HSCT recipients who develop polymicrobial or
multiple microbiologically conﬁrmed infections (MMCI) may
be at increased risk for unfavorable outcomes, yet data is
limited. Herein we report the incidence, risk factors and
survival associated for polymicrobial and multiple microbi-
ologically conﬁrmed infections (MMCI) in 901 HSCT
recipients.
Electronic databases were used for HSCT recipients treated at
Northwestern Memorial Hospital between 2004-09. Infec-
tion data was recorded from the time of admission through
discharge. Any single CONS or VRE BAL culture was excluded
from analysis. Patients received acyclovir, azole antifungal,
and ﬂouroquinolone for prophylaxis. Polymicrobial infection
was deﬁned as the occurrence of 2 MCI's from different
organisms within 72 hours of the 1st positive culture.
Fischers Exact test and Chi-Square was used for analysis of
continuous and discreet variables. This study is IRB
approved.
Amongst 905 HSCT recipients, 59 patients (6.8%) developed
MMCI's. Polymicrobial infection was identiﬁed in 30 (3.4%)
patients. 17 patients had > 2MCI's. Most MCI's (55%) were
blood stream infections. The duration of time which tran-
spired between positive cultures was as follows: Con-
commitant cultures (n¼13), <24 hr (n¼9), 48 hr (n¼8), <72
hr (n¼5), <96 hr (n¼4), <120 hr (n¼3), <144hr (n¼5), >7
days(n¼12). When MMCI'S cases were compared to patients
without any positive cultures using bivariate analysis,
statistically signiﬁcant differences included : female gender
(0.0377), diagnosis of myeloma (P < .0133) or AML (P <
.0497), receipt of allo-HSCT (P < .0001), vancomycin (P <
.0004)or cefepime(P < .0005) use, and positive VRE
